Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research

A Yuri Gasparyan, L Ayvazyan… - Current …, 2012 - ingentaconnect.com
Clinical manifestations of most rheumatic diseases have changed over the past few
decades, largely due to advances in therapies targeting autoimmune and (auto) …

Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis

JF Boyer, A Cantagrel… - Current vascular …, 2008 - ingentaconnect.com
In chronic inflammatory diseases such as rheumatoid arthritis (RA), systemic inflammation
appears as an independent risk factor, contributing to increased cardiovascular mortality …

Cardiovascular safety of biologic therapies for the treatment of RA

JD Greenberg, V Furer, ME Farkouh - Nature reviews Rheumatology, 2012 - nature.com
Cardiovascular disease represents a major source of extra-articular comorbidity in patients
with rheumatoid arthritis (RA). A combination of traditional cardiovascular risk factors and RA …

Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review

A Giollo, LA Bissell, MH Buch - Expert opinion on drug safety, 2018 - Taylor & Francis
Introduction: Rheumatoid arthritis (RA) is associated with a heightened risk of cardiovascular
disease (CVD), with both traditional CV risk factors and inflammation contributing to this risk …

Cardiovascular effects of approved drugs for rheumatoid arthritis

F Atzeni, J Rodríguez-Carrio, CD Popa… - Nature Reviews …, 2021 - nature.com
The risk of cardiovascular disease is increased in patients with rheumatoid arthritis
compared with the general population owing to the influence of traditional and non …

Increased cardiovascular risk in patients with rheumatoid arthritis: an overview

D Puttevils, P De Vusser, P Geusens, J Dens - Acta cardiologica, 2014 - Taylor & Francis
Patients with established rheumatoid arthritis (RA) have a higher cardiovascular morbidity
and mortality in comparison with the general population. It is considered to be an …

[HTML][HTML] Effect of anti-rheumatic drugs on cardiovascular disease events in rheumatoid arthritis

Y Baoqi, M Dan, Z Xingxing, Z Xueqing… - Frontiers in …, 2022 - frontiersin.org
Rheumatoid arthritis (RA) is an autoimmune disease characterized by erosive arthritis,
which can involve multiple systems. Patients with RA may have a variety of comorbidities …

Cardiovascular involvement in systemic rheumatic diseases: an integrated view for the treating physicians

KS Lee, A Kronbichler, M Eisenhut, KH Lee… - Autoimmunity Reviews, 2018 - Elsevier
Systemic autoimmune diseases can affect various kinds of organs including the kidney, the
skin, soft tissue and the bone. Among others, cardiovascular involvement in rheumatic …

[HTML][HTML] Treatment of cardiovascular disease in rheumatoid arthritis: a complex challenge with increased atherosclerotic risk

S Ahmed, B Jacob, SE Carsons, J De Leon, AB Reiss - Pharmaceuticals, 2021 - mdpi.com
Rheumatoid arthritis (RA) carries significant risk for atherosclerotic cardiovascular disease
(ASCVD). Traditional ASCVD risk factors fail to account for this accelerated atherosclerosis …

Cardiovascular risk in rheumatic patients: the link between inflammation and atherothrombosis

MND Di Minno, S Iervolino, R Lupoli… - … in thrombosis and …, 2012 - thieme-connect.com
In addition to a high prevalence of the metabolic syndrome and a significant under-
diagnosis of vascular risk factors (VRFs), the effect of chronic inflammation also represents …